FAP and neoplasm: In a study investigating the role of CAFs in immune suppression for PDAC, Fearon et al. demonstrated that the removal of FAP-positive CAF cells from the tumor in mice models enabled the immune control of tumor growth with anti-PDL-1 immunotherapy [116].